4148 — All Cosmos Bio-Tech Holding Share Price
Last Trade - 00:00- TWD2.08bn
- TWD1.72bn
- TWD1.84bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 2,065.54 | 2,263.65 | 2,687.58 | 1,767.7 | 1,642.78 | 1,904 | n/a | -6.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +20.71 | +23.78 | -10.19 | -87.22 | +110.98 | +48.37 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ALL COSMOS BIO-TECH HOLDING CORPORATION is engaged in the development and use of microbes. The Company’s main products include bio-chemical organic compound fertilizers combined of organic matters, microbes and chemicals, which are applied to the planting of oil palms, as well as compound chemical fertilizers combined of nitrogen, phosphorus and potassium. Chemical fertilizers are applied to provide nutrient elements that plants feed on. The Company’s main operating position is in Malaysia.
Directors
- Shih Hao Peng
- Jingwei Shi
- Chuifeng Lin
- Jialin Peng
- Shengqing Peng
- Genzai Xu
- Luzhang Zhang
- Qianhai Zhu
- Wenquan Li
- Ziwu Luo
- Yongcheng Yang
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- March 26th, 2010
- Public Since
- June 8th, 2017
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 64,034,000
- Address
- Earth Close 64,, PASIR GUDANG, 81700
- Web
- http://www.allcosmos.com/
- Phone
- +60 72523788
- Auditors
- Deloitte & Touche LLP
Upcoming events for 4148
Similar to 4148
ROTAM ORD
Taiwan Stock Exchange
FAQ
As of Today at 19:54 UTC, shares in All Cosmos Bio-Tech Holding are trading at TWD32.55. This share price information is delayed by 15 minutes.
Shares in All Cosmos Bio-Tech Holding last closed at TWD32.55 and the price had moved by -11.79% over the past 365 days. In terms of relative price strength the All Cosmos Bio-Tech Holding share price has underperformed the FTSE Developed Asia Pacific Index by -30.49% over the past year.
The overall consensus recommendation for All Cosmos Bio-Tech Holding is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The All Cosmos Bio-Tech Holding dividend yield is 3.07% based on the trailing twelve month period.
Last year, All Cosmos Bio-Tech Holding paid a total dividend of TWD1.00, and it currently has a trailing dividend yield of 3.07%. We do not have any data on when All Cosmos Bio-Tech Holding is to next pay dividends.
We do not have data on when All Cosmos Bio-Tech Holding is to next pay dividends. The historic dividend yield on All Cosmos Bio-Tech Holding shares is currently 3.07%.
To buy shares in All Cosmos Bio-Tech Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TWD32.55, shares in All Cosmos Bio-Tech Holding had a market capitalisation of TWD2.08bn.
Here are the trading details for All Cosmos Bio-Tech Holding:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4148
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
All Cosmos Bio-Tech Holding does not currently have a style classification.
The analyst consensus target price for shares in All Cosmos Bio-Tech Holding is TWD97.00. That is 198% above the last closing price of TWD32.55.
Analysts covering All Cosmos Bio-Tech Holding currently have a consensus Earnings Per Share (EPS) forecast of TWD1.90 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like All Cosmos Bio-Tech Holding. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -6.41%.
As of the last closing price of TWD32.55, shares in All Cosmos Bio-Tech Holding were trading -8.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The All Cosmos Bio-Tech Holding PE ratio based on its reported earnings over the past 12 months is 19.50. The shares last closed at TWD32.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
All Cosmos Bio-Tech Holding's management team is headed by:
- Shih Hao Peng -
- Jingwei Shi -
- Chuifeng Lin -
- Jialin Peng -
- Shengqing Peng -
- Genzai Xu -
- Luzhang Zhang -
- Qianhai Zhu -
- Wenquan Li -
- Ziwu Luo -
- Yongcheng Yang -
We do not have data on All Cosmos Bio-Tech Holding's shareholders